Spero Therapeutics ( ($SPRO) ) has provided an announcement. On August 12, 2025, Spero Therapeutics announced its second quarter 2025 financial ...

One of the most significant biomedical achievements of the 21st century, mRNA vaccines have reshaped the world’s ability to ...

The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...

South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...

GSK plc announced the acquisition of ordinary shares by several key executives under the Company’s Share Reward Plan. This transaction, conducted on the London Stock Exchange, involved the purchase of ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

Former Surgeon General weighs in on CDC shooting; Novartis aces Sjögren's disease trials; U.K. pharma industry at inflection point amid tariff threats.

The United States Epilepsy Drugs Market is projected to grow from US$ 2.36 billion in 2024 to US$ 3.45 billion by 2033, ...

The viral vector vaccines market, driven by innovation and global demand, offers expanding opportunities in immunization, notably for diseases like C ...

Investing.com -- GlaxoSmithKline (NYSE: GSK) Bioc announced its financial results for the second quarter, reporting a consolidated net profit attributable of EGP 5.9 million. The company also reported ...

London: GSK plc has announced that a supplemental New Drug Application for gepotidacin has been accepted by the US Food and ...